NO20070669L - Fremgangsmate for fremstillingen av en prioksikam: betacyklodekstrininklusjonsforbindelse - Google Patents

Fremgangsmate for fremstillingen av en prioksikam: betacyklodekstrininklusjonsforbindelse

Info

Publication number
NO20070669L
NO20070669L NO20070669A NO20070669A NO20070669L NO 20070669 L NO20070669 L NO 20070669L NO 20070669 A NO20070669 A NO 20070669A NO 20070669 A NO20070669 A NO 20070669A NO 20070669 L NO20070669 L NO 20070669L
Authority
NO
Norway
Prior art keywords
beta
preparation
inclusion compound
prioxy
comb
Prior art date
Application number
NO20070669A
Other languages
English (en)
Norwegian (no)
Inventor
Roberto Pighi
Soren Fjordgaard Andresen
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20070669L publication Critical patent/NO20070669L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20070669A 2004-08-02 2007-01-31 Fremgangsmate for fremstillingen av en prioksikam: betacyklodekstrininklusjonsforbindelse NO20070669L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04018261 2004-08-02
PCT/EP2005/008105 WO2006013039A2 (en) 2004-08-02 2005-07-26 A process for the preparation of a piroxicam: beta­cyclodextrin inclusion compound

Publications (1)

Publication Number Publication Date
NO20070669L true NO20070669L (no) 2007-05-02

Family

ID=35502714

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070669A NO20070669L (no) 2004-08-02 2007-01-31 Fremgangsmate for fremstillingen av en prioksikam: betacyklodekstrininklusjonsforbindelse

Country Status (17)

Country Link
US (1) US20090012284A1 (pl)
EP (1) EP1793862B1 (pl)
JP (1) JP2008508332A (pl)
KR (1) KR20070038109A (pl)
CN (1) CN101123989B (pl)
AT (1) ATE502653T1 (pl)
AU (1) AU2005268972A1 (pl)
DE (1) DE602005027092D1 (pl)
IL (1) IL181101A0 (pl)
MA (1) MA28849B1 (pl)
MX (1) MX2007001237A (pl)
NO (1) NO20070669L (pl)
PL (1) PL1793862T3 (pl)
PT (1) PT1793862E (pl)
TN (1) TNSN07012A1 (pl)
WO (1) WO2006013039A2 (pl)
ZA (1) ZA200700946B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101491529B (zh) * 2009-01-23 2011-04-06 上海微丸医药开发有限公司 一种吡罗昔康β-环糊精包合物微丸胶囊的制备方法
BR102012009317B1 (pt) * 2012-04-20 2022-05-31 Universidade Federal De Minas Gerais - Ufmg Processo de preparação de compostos de inclusão envolvendo ciclodextrinas e fármacos, usando um sistema de fluxo contínuo
WO2014161131A1 (en) * 2013-04-01 2014-10-09 Arissa Pharma PREPARING AMORPHOUS MELOXICAM-β-CYCLODEXTRIN INCLUSION COMPLEX VIA SPRAY DRYING PROCESS
WO2015001133A1 (en) * 2013-12-12 2015-01-08 Synthon B.V. Pharmaceutical composition comprising amorphous ivabradine
EP3302781B1 (en) * 2015-05-29 2020-09-16 Givaudan S.A. Spray drying
US20170056253A1 (en) * 2015-08-28 2017-03-02 Fitesa Nonwoven, Inc. Absorbent Article Having A High Content Of Bio-Based Materials
JP7138643B2 (ja) * 2017-01-09 2022-09-16 サイファーム ソシエテ ア レスポンサビリテ リミテ 水溶性フォルスコリンの新規製造法
CN111148491B (zh) * 2017-09-21 2023-04-07 宝洁公司 吸收制品
CN110575550A (zh) * 2019-08-13 2019-12-17 大梆(沈阳)动物保健有限公司 一种遮蔽兽用复方中药不良嗅味的方法
CN112471565A (zh) * 2020-12-18 2021-03-12 鲁南制药集团股份有限公司 一种挥发油喷雾研磨包合设备

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
ZA941544B (en) * 1993-03-05 1994-10-31 Hexal Pharma Gmbh Crystalline cyclodextrin complexes of ranitidine hydrochloride, process for their preparation and pharmaceutical compositions containing the same.
KR20030041577A (ko) * 2001-11-20 2003-05-27 디디에스텍주식회사 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물
WO2006011044A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Amorphous cyclodextrin compositions

Also Published As

Publication number Publication date
DE602005027092D1 (de) 2011-05-05
ZA200700946B (en) 2008-06-25
ATE502653T1 (de) 2011-04-15
PL1793862T3 (pl) 2011-08-31
PT1793862E (pt) 2011-04-08
HK1116054A1 (en) 2008-12-19
WO2006013039A2 (en) 2006-02-09
KR20070038109A (ko) 2007-04-09
AU2005268972A1 (en) 2006-02-09
MX2007001237A (es) 2007-04-18
EP1793862A2 (en) 2007-06-13
EP1793862B1 (en) 2011-03-23
JP2008508332A (ja) 2008-03-21
CN101123989B (zh) 2010-12-15
TNSN07012A1 (en) 2008-06-02
IL181101A0 (en) 2007-07-04
CN101123989A (zh) 2008-02-13
US20090012284A1 (en) 2009-01-08
MA28849B1 (fr) 2007-09-03
WO2006013039A3 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
NO20070669L (no) Fremgangsmate for fremstillingen av en prioksikam: betacyklodekstrininklusjonsforbindelse
WO2009108828A3 (en) Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof
WO2008003766A3 (en) 4-heter0cycl0alkylpyri(mi)dines, process for the preparation thereof and their use as medicaments
NO20064588L (no) Delta d-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende den
WO2008012542A8 (en) Polysaccharide derivatives of erythropoietin
CY1107693T1 (el) Μεθοδος παρασκευης ενωσεων εγκλεισμου πιροξικαμησ:β-κυκλοδεξτρινης
WO2006021379A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
WO2008009831A3 (fr) Derives de cyclodextrines amphiphiles
WO2007115210A3 (en) Non-starchy rice bran polysaccharides
WO2007083060A3 (fr) Derives de chalcone a activite antimitotique
WO2006117211A3 (en) Urea derivatives methods for their manufacture and uses thereof
MXPA05012679A (es) Nuevos derivados de imidazoles, su preparacion y su uso como medicamento.
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
UA95088C2 (ru) Композиция, которая содержит наночастички связанные с биосовместимым полимером противоракового агента и снижает аллопецию при химиотерапии, способ ее получения
GEP20094745B (en) Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same
WO2010018474A3 (fr) Nouveaux derives de glucopyranose, leur preparation et leurs applications biologiques
WO2009043577A3 (de) 19-nor-progesterone zur kontrazeption
UA88182C2 (ru) Композиция, которая содержит эпотилон (варианты), и способ ее получения (варианты)
GEP20094744B (en) Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same
WO2006099940A8 (de) Substituierte, bizyklische 8-pyrrolidino-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2007079715A3 (de) Neue lysolipin derivate
EA200601842A1 (ru) D-гомо-17-хлор-16(17)-ен-стероиды
WO2007079198A3 (en) Metaxalone formulations and methods for the preparation thereof
CY1113971T1 (el) Νεα παραγωγα αζαδικυκλο [3.2.0] επτ-3-υλ, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις που τα περιεχουν
WO2008102584A1 (ja) 新規フラバノール化合物及びその製造方法

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application